前列腺癌患者获得息性放射治疗的变化:加拿大的基于人口的研究
Alborz Jooya1, Daniel Qureshi2, William J Phillips3
1Department of Radiation Oncology, Princess Margaret Cancer Centre, University Health Network (UHN), Toronto, CAN.
Cureus
|March 25, 2024
概括
在安大略省,近一半的前列腺癌患者在死亡前接受了息性放射治疗. 年龄较小,更高的阶段和在区域癌症中心的护理等因素与其使用有关,突出了改善获取机会的机会.
科学领域:
- 在瘤学瘤学.
- 抚慰性护理是一种缓解性护理.
- 辐射瘤学 辐射瘤学
背景情况:
- 转移性癌症生存率的提高需要认识到息性放射治疗的作用.
- 获得缓解性放射治疗仍然是一个挑战,许多前列腺癌患者在死亡前没有接受它.
- 本研究调查了影响安大略省已故前列腺癌患者接受息性放射治疗的因素.
研究的目的:
- 识别和描述与息性放射治疗利用相关的因素.
- 分析前列腺癌患者死亡队列中接受放射治疗的预测因素.
- 为改善人们获得息性放射治疗的策略提供信息.
主要方法:
- 利用了来自加拿大安大略省的基于人口的行政数据库.
- 鉴定了65岁以上的前列腺癌死者,这些死者接受了雌激素剥夺疗法 (2013-2018).
- 分析了基线和治疗特征,使用后勤回归来研究与死亡后两年内接受放射治疗的关联.
主要成果:
- 在3788名已确诊的前列腺癌患者中,有49.9%的患者在死亡前两年接受了放射治疗.
- 发现的积极关联是诊断时年龄较小,癌症阶段较高,以及在区域癌症中心的护理.
- 接受放射瘤学家或医学瘤学家的护理与放射治疗的使用密切相关;与收入或癌症中心距离无关.
结论:
- 在安大略省的前列腺癌患者中,息性放射治疗的利用因年龄,阶段,并发症和治疗中心类型而异.
- 没有与患者的收入或癌症中心的邻近性有关的差异.
- 研究结果表明,有机会加强息性放射治疗的准入和转诊到多学科中心,以改善患者的生活质量.
相关概念视频
01:21Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
01:30Cancer Vaccines
363
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
363